Implementation of evidence-based pharmacotherapy for individuals with opioid use disorder
(OUD) is a cornerstone of the response to the opioid crisis [
[1]
]. ED-initiated OUD treatment with buprenorphine has been shown to increase treatment
engagement at 30 days [
[2]
], but this practice has not been widely adopted [
[3]
]. To better develop strategies for implementation, we sought to 1) describe ED physician
preparedness to treat OUD and 2) rank physician-perceived barriers and facilitators
of ED administration of buprenorphine and obtaining a Drug Addiction Treatment Act
of 2000 waiver to prescribe buprenorphine (X-waiver).- Martin A.
- Mitchell A.
- Wakeman S.
- White B.
- Raja A.
Emergency department treatment of opioid addiction: an opportunity to Lead.
Acad Emerg Med Off J Soc Acad Emerg Med. 2017; https://doi.org/10.1111/acem.13367
Keywords
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Understanding the epidemic. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention.(Accessed December 15, 2018, at)
- Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.JAMA. 2015; 313: 1636-1644https://doi.org/10.1001/jama.2015.3474
- Emergency department treatment of opioid addiction: an opportunity to Lead.Acad Emerg Med Off J Soc Acad Emerg Med. 2017; https://doi.org/10.1111/acem.13367
- Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.Fam Med. 2006; 38: 336-340
- Barriers to primary care physicians prescribing buprenorphine.Ann Fam Med. 2014; 12: 128-133https://doi.org/10.1370/afm.1595
- Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.Rural Remote Health. 2015; 15: 3019
- Why aren't physicians prescribing more buprenorphine?.J Subst Abuse Treat. 2017; 78: 1-7https://doi.org/10.1016/j.jsat.2017.04.005
- Capone MJ. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices.Int J Drug Policy. 2018; 54: 9-17https://doi.org/10.1016/j.drugpo.2017.11.021
- Policy pathways to address provider workforce barriers to buprenorphine treatment.Am J Prev Med. 2018; 54: S230-s42https://doi.org/10.1016/j.amepre.2017.12.022
- Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform. 2009; 42: 377-381https://doi.org/10.1016/j.jbi.2008.08.010
- "We've learned It's a medical illness, not a moral choice": qualitative study of the effects of a multicomponent addiction intervention on hospital Providers' attitudes and experiences.J Hosp Med. 2018; 13: 752-758https://doi.org/10.12788/jhm.2993
- Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X waiver.JAMA Psychiat. 2018; https://doi.org/10.1001/jamapsychiatry.2018.3685
Article Info
Publication History
Published online: February 18, 2019
Accepted:
February 18,
2019
Received in revised form:
February 16,
2019
Received:
February 7,
2019
Identification
Copyright
Published by Elsevier Inc.
